Monthly Archives: October 2016

Panorama Study For Patients With Diabetic Retinopathy

Clinical Trial for Patients with NPDR Dear Respected Colleague, We are pleased to inform you that CFR is participating as a recruiting study site in the Regeneron Pharmaceuticals, Inc. PANORAMA study: a phase 3 study of the efficacy and safety of intravitreal (IVT) aflibercept in patients with moderately severe to severe NPDR. Approximately 360 patients […]

Read More
Partner Logos
WARNING: Internet Explorer does not support modern web standards. This site may not function correctly on this browser and is best viewed on Chrome, Firefox or Edge browsers. Learn More.